Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EUCR

Eucrates Biomedical Acquisition (EUCR) Stock Price, News & Analysis

Eucrates Biomedical Acquisition logo

About Eucrates Biomedical Acquisition Stock (NASDAQ:EUCR)

Advanced Chart

Key Stats

Today's Range
$10.02
$10.04
50-Day Range
$10.04
$10.25
52-Week Range
$9.87
$10.25
Volume
12,700 shs
Average Volume
2,287 shs
Market Capitalization
$42.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EUCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eucrates Biomedical Acquisition and its competitors with MarketBeat's FREE daily newsletter.

EUCR Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
8-K: Eucrates Biomedical Acquisition Corp.
See More Headlines

EUCR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Eucrates Biomedical Acquisition investors own include Sprott Focus Trust (FUND), Meta Platforms (META), ETFMG Alternative Harvest ETF (MJX), New Zealand Energy (NZ), Strathcona Resources (SCR) and Shopify (SHOP).

Company Calendar

Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:EUCR
CIK
1822929
Web
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$2.42 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-62.82%
Return on Assets
2.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.03
Quick Ratio
2.03

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
$0.81 per share
Price / Cash Flow
12.36
Book Value
($1.25) per share
Price / Book
-8.03

Miscellaneous

Outstanding Shares
4,210,000
Free Float
3,386,000
Market Cap
$42.27 million
Optionable
Not Optionable
Beta
-0.07
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:EUCR) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners